Physician profile
Ted A Kovacev
NPI 1568614402
$24,913.02
in general payments reported to CMS, 2019-2025
31 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $718 · 2021: $1,220 · 2022: $555 · 2023: $1,137 · 2024: $1,139 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $19K · Food and Beverage: $2,839 · Travel and Lodging: $24.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $19,200.00 |
| Food and Beverage | $2,838.56 |
| Travel and Lodging | $24.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $19,286.97 | 2023-2025 | |
| Smith+Nephew, INC. | $2,920.08 | 2019-2025 | Grafix Pl, Grafix, Renasys Touch |
| Stryker Corporation | $610.50 | 2021 | |
| Intuitive Surgical, INC. | $391.10 | 2019-2020 | |
| Medline Industries LP | $279.65 | 2020 | |
| Cook Biotech Incorporated | $248.93 | 2023 | Biodesign |
| Davol INC. | $198.34 | 2020-2023 | Phasix Mesh |
| Kerecis Limited | $180.47 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Stability Biologics, LLC | $123.63 | 2024 | |
| Organogenesis INC. | $77.76 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $71.08 | 2021-2022 | |
| Misonix INC | $61.23 | 2020 | |
| Boston Scientific Corporation | $58.55 | 2021-2022 | |
| Checkpoint Surgical, INC | $44.85 | 2024-2025 | Checkpoint Stimulators |
| Ets Wound Care LLC | $40.35 | 2023-2024 | Mirragen Advanced Wound Matrix |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $34.00 | 2020-2023 | Promogran Prisma, Activ.A.C. |
| Ethicon US, LLC | $29.50 | 2021 | |
| Tela Bio, INC. | $26.75 | 2024 | Ovitex 2s |
| Thd America, INC. | $25.90 | 2023 | |
| Cook Medical LLC | $24.68 | 2023 | Neff |
| Becton, Dickinson and Company | $20.62 | 2022 | |
| Aroa Biosurgery Incorporated | $20.34 | 2024 | |
| Medtronic, INC. | $20.18 | 2021 | |
| Olympus America INC. | $19.78 | 2024 | Endoclot Phs |
| Bioventus LLC | $18.91 | 2023 | |
| Innocoll Pharmaceuticals Limited | $17.74 | 2021 | |
| Coopersurgical, INC. | $15.27 | 2021 | |
| Apollo Endosurgery US INC | $13.46 | 2021 | |
| Triad Life Sciences INC. | $12.84 | 2022 | |
| Conmed Corporation | $12.40 | 2020 | |
| Biomerieux INC | $7.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Kovacev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.